Literature DB >> 12464233

The skeletal dysplasias.

Ravi Savarirayan1, David L Rimoin.   

Abstract

The skeletal dysplasias are a large, heterogeneous group of genetic conditions characterized by abnormal development, growth and maintenance of the elements (bones) that comprise the human skeleton. Many result in disproportionate short stature. The classification of these disorders has evolved over the past 30 years from purely clinical-pathological descriptions to a nosology that now also reflects their underlying molecular aetiology. Accurate diagnosis of these disorders requires comprehensive documentation of the history, analysis of longitudinal growth patterns, rigorous clinical evaluation of the individual and family, complete radiographic survey and, when available, examination of chondro-osseous specimens. The specific genetic defects underlying many of these conditions have now been elucidated, allowing links to be established between phenotype and genotype. Management revolves around treatment to prevent or minimize medical complications, psychosocial support of patients and their families, education of the medical profession and wider community and modification of the environment where appropriate.

Entities:  

Mesh:

Year:  2002        PMID: 12464233     DOI: 10.1053/beem.2002.0210

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  6 in total

Review 1.  Advances in Skeletal Dysplasia Genetics.

Authors:  Krista A Geister; Sally A Camper
Journal:  Annu Rev Genomics Hum Genet       Date:  2015-04-22       Impact factor: 8.929

2.  Acute Type A Dissection Repair in an Achondroplastic Dwarf: Anesthetic, Perfusion, and Surgical Concerns.

Authors:  Mohammed Al-Jughiman; Bobby Yanagawa; Kevin Rondi; Constantine Dalamagas; Mark D Peterson; Daniel Bonneau
Journal:  Aorta (Stamford)       Date:  2014-08-01

Review 3.  Skeletal Dysplasias: Growing Therapy for Growing Bones.

Authors:  Angie C Jelin; Elizabeth O'Hare; Karin Blakemore; Eric B Jelin; David Valle; Julie Hoover-Fong
Journal:  Front Pharmacol       Date:  2017-03-06       Impact factor: 5.810

Review 4.  Optimal management of complications associated with achondroplasia.

Authors:  Penny J Ireland; Verity Pacey; Andreas Zankl; Priya Edwards; Leanne M Johnston; Ravi Savarirayan
Journal:  Appl Clin Genet       Date:  2014-06-24

5.  Limb lengthening in achondroplasia.

Authors:  Sanjay K Chilbule; Vivek Dutt; Vrisha Madhuri
Journal:  Indian J Orthop       Date:  2016 Jul-Aug       Impact factor: 1.251

6.  Identification and in silico characterization of p.G380R substitution in FGFR3, associated with achondroplasia in a non-consanguineous Pakistani family.

Authors:  Muhammad Ajmal; Asif Mir; Muhammad Shoaib; Salman Akbar Malik; Muhammad Nasir
Journal:  Diagn Pathol       Date:  2017-07-05       Impact factor: 2.644

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.